Tata Chemicals Q4 FY26 Results with $208M Impairment

Tata Chemicals reported Q4 FY26 consolidated revenue of INR 3,438 crore, down 2% YoY, with EBITDA at INR 274 crore, impacted by subdued global soda ash prices.
The company recorded an exceptional charge of INR 1,837 crore for goodwill impairment in its US operations and a INR 159 crore deferred tax write-off.
Management highlighted operational challenges from Middle East conflict, including higher energy costs and supply chain disruptions, particularly for Kenyan HFO supplies.
Strategic focus remains on growing non-soda ash revenue, which increased 14% to INR 6,946 crore in FY26, with FY27 capex planned at INR 1,300 crore.